0001552622-19-000001.txt : 20191108 0001552622-19-000001.hdr.sgml : 20191108 20191107194847 ACCESSION NUMBER: 0001552622-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191107 EFFECTIVENESS DATE: 20191108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InCarda Therapeutics, Inc. CENTRAL INDEX KEY: 0001552622 IRS NUMBER: 264521716 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352920 FILM NUMBER: 191201808 BUSINESS ADDRESS: STREET 1: 39899 BALENTINE DRIVE, SUITE 185 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 408-219-2576 MAIL ADDRESS: STREET 1: 39899 BALENTINE DRIVE, SUITE 185 CITY: NEWARK STATE: CA ZIP: 94560 D 1 primary_doc.xml X0708 D LIVE 0001552622 InCarda Therapeutics, Inc. 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA CALIFORNIA 94560 408-219-2576 DELAWARE Pleiades Cardio-Therapeutics, Inc. None Corporation true Grace Colon 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Executive Officer Director Isaac Cheng 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Bischofberger Norbert 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Alan Colowick 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Johan Christenson 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Andrew ElBardissi 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Dan Welch 39899 BALENTINE DRIVE, SUITE 185 Newark CA CALIFORNIA 94560 Director Pharmaceuticals Decline to Disclose 06b false 2017-10-20 true true false 1791 42127033 35296018 6831015 false 24 0 0 0 Proceeds to be used as working capital, including payment of director, officer and employee salaries. false InCarda Therapeutics, Inc. /Grace Colon/ Grace Colon CEO and President 2019-11-07